Novel Agents that Potentially Inhibit Irinotecan-Induced Diarrhea

E-ISSN： 1875-533x|12|11|1343-1358

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.11, 2005-06, pp. : 1343-1358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotide effective in treatment of irinotecan-induced diarrhoea

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Novel agents to inhibit microbial virulence and pathogenicity

By Escaich Sonia

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 10, 2010-10 ,pp. : 1401-1418

Informa Healthcare

Access to resources Recommend Favorite

Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents

Current Pharmaceutical Design, Vol. 12, Iss. 26, 2006-09 ,pp. : 3411-3421

Bentham Science Publishers

Access to resources Recommend Favorite

Gangliosides Potentially Inhibit Extracellular Nucleotide Metabolism

Current Medicinal Chemistry, Vol. 13, Iss. 19, 2006-08 ,pp. : 2233-2239

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Combination of Cisplatin, Irinotecan, and Capecitabine in Patients with Advanced Cancer

By Jefford Michael Michael Michael Rosenthal Mark A. Davis Ian D. Green Michael McClure Bev Smith Jennifer Waite Brigid Zalcberg John

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite